SAGE THERAPEUTICS LIMITED
Company number 10646688 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£2,094,431
Balance sheet as at 2024-12-31
What it does
The principal activity of the company is to provide research and support to the parent
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-03-01
- Employees
- 3 (2024 accounts)
- Registered office
- C/O Company Secretarial Department, 280 Bishopsgate, London, United Kingdom, EC2M 4AG
- Postcode
- EC2M 4AG
- Capital
- 1 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-12-31
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-25
- Next due by
- 2027-03-11
Nature of business (SIC)
- 21200 Manufacture of pharmaceutical preparations
- 46460 Wholesale of pharmaceutical goods
Officers 5 current · 5 resigned
Group structure
Controlled by Supernus Pharmaceuticals, Inc. (EIN20-2590184) — since 2025-07-31
Controlled by Sage Therapeutics, Inc. (04812455) — since 2017-03-01
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA291903 (Tier 1), registered since 2017.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Among its peers
Top 25%
by shareholders' funds, of 19 similar companies in EC
Trading since 2017.
Competitors London
This company ranks 4 among manufacture of pharmaceutical preparations in London.
The class of 2017
28%
of the 636,544 companies incorporated in 2017 are still active today; 66% have since been dissolved.
A fact about the year, not a forecast for this company.